Provention Bio Inc.

NASDAQ: PRVB · Real-Time Price · USD
24.98
0.00 (0.00%)
At close: Apr 26, 2023, 10:00 PM

Provention Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
44.04M 78.19M
Short-Term Investments
120.96M 16.92M
Long-Term Investments
n/a 32.02M
Other Long-Term Assets
120K 120K
Receivables
1.36M n/a
Inventory
1.23M n/a
Other Current Assets
7.06M 5.99M
Total Current Assets
174.65M 101.1M
Property-Plant & Equipment
2.53M 2.38M
Goodwill & Intangibles
59.56M n/a
Total Long-Term Assets
62.21M 34.52M
Total Assets
236.86M 135.62M
Account Payables
6.76M 3.55M
Deferred Revenue
17.69M 5.6M
Short-Term Debt
n/a n/a
Other Current Liabilities
65.94M 13.65M
Total Current Liabilities
90.39M 22.79M
Long-Term Debt
23.91M 590K
Other Long-Term Liabilities
n/a n/a
Total Long-Term Liabilities
24.62M 2.1M
Total Liabilities
115.01M 24.89M
Total Debt
23.91M 590K
Common Stock
9K 6K
Retained Earnings
-405.64M -292.07M
Comprehensive Income
-647K -139K
Shareholders Equity
121.85M -292.07M
Total Investments
120.96M 48.94M